Stewart Christopher P. 4
4 · Bionano Genomics, Inc. · Filed Nov 23, 2021
Insider Transaction Report
Form 4
Stewart Christopher P.
Chief Financial Officer
Transactions
- Exercise/Conversion
Common Stock
2021-11-19$0.56/sh+22,500$12,600→ 55,500 total - Exercise/Conversion
Stock Option (Right to Buy)
2021-11-19−22,500→ 177,500 totalExercise: $0.56Exp: 2030-09-01→ Common Stock (22,500 underlying)
Footnotes (1)
- [F1]The shares vest in full on December 31, 2020, subject to Reporting Person's continuous service through December 31, 2020, subject to acceleration of vesting provided in the Employment Agreement, dated as of September 1, 2020, by and between the Issuer and the Reporting Person.